Completed PHASE1 INTERVENTIONAL 2-arm NCT05202912

Food Effect Study of IDX-1197 in Healthy Subjects

A Randomized, Open-label, Single-dose, Crossover Phase 1 Clinical Trial to Evaluate the Effects of Food or Ethnicity on the Pharmacokinetics and Safety/Tolerability of IDX-1197 After Single Oral Administration in Healthy Male Korean, Chinese, and Caucasian Volunteers

Sponsor: Idience Co., Ltd.

Conditions Healthy Male

Interventions IDX-1197(After a meal) IDX-1197(fasting)

Updated 5 times since 2022 Last updated: Aug 7, 2022 Started: Jan 16, 2022 Primary completion: Jul 23, 2022 Completion: Jul 23, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Male and is currently completed. Idience Co., Ltd. leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Sep 2022 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Feb 2022 — Sep 2022 [monthly]

Recruiting PHASE1

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Idience Co., Ltd.

Data source: Idience Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea